Asceneuron Expands Scientific Advisory Board with World Leading Experts in Neurodegenerative Diseases

Asceneuron United Kingdom United States of America Switzerland

Significant appointments of industry and academic experts to support Phase II development of ASN51 in Alzheimer's disease View original content:https://www.prnewswire.co.uk/news-releases/asceneuron-expands-scientific-advisory-board-with-world-leading-experts-in-neurodegenerative-diseases-302080348.html